Type 2 diabetes, vildagliptin
Showing 1 - 25 of >10,000
Type 2 Diabetes Trial in Damanhur (Vildagliptin 50 MG, Glimepiride 3 Mg Oral Tablet)
Recruiting
- Type 2 Diabetes
- Vildagliptin 50 MG
- Glimepiride 3 Mg Oral Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 29, 2023
Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)
Completed
- Type 2 Diabetes
-
Karachi, Sindh, PakistanDepartment of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022
Diabetes, Type 2 Trial in Shinjuku-Ku (Imeglimin, Metformin, Vildagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Imeglimin
- +2 more
-
Shinjuku-Ku, Tokyo, JapanCenter Hospital of the National Center for Global Health and Med
Sep 26, 2022
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
Metformin and DPP4 Inhibitors on Cognition and Cardiovascular
Recruiting
- Type 2 Diabetes Mellitus
-
Cairo, Al Kasr Al Aini, EgyptNational Institute of diabetes and endocrinology
Jun 19, 2022
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Diabetes, Type 2 Trial in Minya (Vildagliptin 50 MG, Sitagliptin 100mg, MetFORMIN 1000 Mg Oral Tablet)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin 50 MG
- +2 more
-
Minya, EgyptMinya University Hospital
Jun 4, 2021
Type 2 Diabetes Trial in Mexico (Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg), Glimepiride / Vildagliptin /
Not yet recruiting
- Type 2 Diabetes
- Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg)
- Glimepiride / Vildagliptin / Metformin (4 mg/ 50 mg/ 1000 mg)
-
Cancún, Quintana Roo, Mexico
- +4 more
Jun 8, 2021
Type 2 Diabetes Trial in Tokyo (Vildagliptin (LAF237), Voglibose, Vildagliptin and Voglibose)
Completed
- Type 2 Diabetes
- Vildagliptin (LAF237)
- +2 more
-
Tokyo, JapanNovartis Investigative Site
Dec 16, 2020
Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +4 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover (Vildagliptin, pioglitazone, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New JerseyNovartis Pharmaceuticals
Dec 11, 2020
Diabetes, Type 2 Trial in Baltimore (Vildagliptin)
Terminated
- Diabetes Mellitus, Type 2
-
Baltimore, MarylandNovartis Investigator Site
Dec 11, 2020
Diabetes, Type 2 Trial in Basel (vildagliptin, )
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- placebo
-
Basel, SwitzerlandNovartis Pharmaceuticals
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, Metformin, Vildagliptin + Metformin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in Nurnberg, Basel (Vildagliptin 100 mg qd, Metformin 1500 mg daily)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin 100 mg qd
- Metformin 1500 mg daily
-
Nurnberg, Germany
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, metformin)
Completed
- Diabetes Mellitus, Type 2
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in San Antonio (vildagliptin + metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin + metformin
-
San Antonio, TexasDiabetes and Glandular Disease Research Associates
Dec 11, 2020
Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- Placebo
-
Buenos Aires, Argentina
- +11 more
Dec 11, 2020
Diabetes, Type 1 Trial in Milan (rapamycin, Vildagliptin, Placebo 1)
Completed
- Diabetes Mellitus, Type 1
- rapamycin
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Nov 2, 2020
Coronary Artery Disease, Diabetes, Type 2 Trial in Damanhur (Vildagliptin 50 mg Oral Tablet, Metformin 1000 mg Oral Tablet,
Completed
- Coronary Artery Disease
- Diabetes Mellitus, Type 2
- Vildagliptin 50 mg Oral Tablet
- +2 more
-
Damanhūr, EgyptFaculty of Pharmacy - Damanhour University.
Dec 24, 2020
Diabetes, Type 2 Trial in Kuching (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
-
Kuching, MalaysiaSarawak General Hospital
Dec 16, 2020